These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29867033)

  • 21. HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis.
    Cornejo Castro EM; Carr DF; Jorgensen AL; Alfirevic A; Pirmohamed M
    Pharmacogenet Genomics; 2015 Apr; 25(4):186-98. PubMed ID: 25714001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies.
    Smith KD; Mace BE; Valenzuela A; Vigna JL; McCutcheon JA; Barbosa JA; Huczko E; Engelhard VH; Lutz CT
    J Immunol; 1996 Sep; 157(6):2470-8. PubMed ID: 8805647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico design of high-affinity antigenic peptides for HLA-B44.
    Feng M; Chan KC; Zhong Q; Zhou R
    Int J Biol Macromol; 2024 May; 267(Pt 2):131356. PubMed ID: 38574928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2 vaccination.
    Aharon A; Benedek G; Barhoum B; Parnasa E; Magadle N; Perzon O; Mevorach D
    Eur J Clin Invest; 2024 Apr; 54(4):e14142. PubMed ID: 38071404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population.
    Baleotti W; Ruiz MO; Fabron A; Castilho L; Giuliatti S; Donadi EA
    Transfusion; 2014 Oct; 54(10):2468-76. PubMed ID: 24724911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomewide association study of peanut allergy reproduces association with amino acid polymorphisms in HLA-DRB1.
    Martino DJ; Ashley S; Koplin J; Ellis J; Saffery R; Dharmage SC; Gurrin L; Matheson MC; Kalb B; Marenholz I; Beyer K; Lee YA; Hong X; Wang X; Vukcevic D; Motyer A; Leslie S; Allen KJ; Ferreira MA
    Clin Exp Allergy; 2017 Feb; 47(2):217-223. PubMed ID: 27883235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome.
    Watanabe H; Watanabe Y; Tashiro Y; Mushiroda T; Ozeki T; Hashizume H; Sueki H; Yamamoto T; Utsunomiya-Tate N; Gouda H; Kusakabe Y
    J Dermatol Sci; 2017 Dec; 88(3):320-329. PubMed ID: 28870516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docking simulations between drugs and HLA molecules associated with idiosyncratic drug toxicity.
    Hirayama N
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):31-39. PubMed ID: 27964952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis.
    Gerasimou P; Nicolaidou V; Skordis N; Picolos M; Monos D; Costeas PA
    PLoS One; 2018; 13(3):e0193684. PubMed ID: 29494662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
    Kritikou-Griva E; Spyropoulou-Vlachou M; Tsagarakis NJ; Goumakou E; Vrani V; Galanopoulos A; Papadhimitriou SI; Androutsos G; Paterakis G; Stavropoulos-Giokas C
    Hum Immunol; 2012 Mar; 73(3):278-81. PubMed ID: 22244918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
    Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
    J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence-based typing of a novel HLA-DRB1*04 allele, DRB1*0461, in a Taiwanese volunteer marrow donor.
    Chen MJ; Chu CC; Lin PY; Yang KL
    Int J Immunogenet; 2007 Aug; 34(4):269-72. PubMed ID: 17627762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.
    Hill CM; Liu A; Marshall KW; Mayer J; Jorgensen B; Yuan B; Cubbon RM; Nichols EA; Wicker LS; Rothbard JB
    J Immunol; 1994 Mar; 152(6):2890-8. PubMed ID: 8144889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DRB1 polymorphism is associated with Kell immunisation.
    Chiaroni J; Dettori I; Ferrera V; Legrand D; Touinssi M; Mercier P; de Micco P; Reviron D
    Br J Haematol; 2006 Feb; 132(3):374-8. PubMed ID: 16409303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Zhou P; Zhang S; Wang Y; Yang C; Huang J
    J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein.
    Scapozza L; Rognan D; Folkers G; Daser A
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):541-9. PubMed ID: 15299842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.